InvestorsHub Logo
Followers 144
Posts 27607
Boards Moderated 3
Alias Born 02/07/2004

Re: midastouch017 post# 1881

Wednesday, 06/29/2022 7:44:03 AM

Wednesday, June 29, 2022 7:44:03 AM

Post# of 2043
"Based on Piclidenoson’s safety and efficacy data revealed in this trial, we plan to approach the U.S. FDA and the European EMA with a protocol for a pivotal Phase III study for drug approval and registration," stated Can-Fite CEO, Dr. Pnina Fishman.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CANF News